medtronic infuse lawsuit settlement amounts

#Medtronic infuse lawsuit settlement amounts for free

Medtronic denied any wrongdoing and said it did not promote off-label use of its products. In a statement, the UCLA Health System said the regents agreed to settle the two cases “so that UCLA Health and the David Geffen School of Medicine at UCLA could move forward with their ongoing commitment to excellence in patient care, research, education and community service.”

#Medtronic infuse lawsuit settlement amounts for free

It can be republished for free ( details). This story also ran in the Los Angeles Times.

Wang, through his attorney, declined to comment. The UC system and Wang, now co-director of the University of Southern California Spine Center, denied any wrongdoing in court documents. “I was astonished and offended when I found out about the conflicts that were never disclosed to me.” Wang for my spine surgery based upon their sterling reputations,” Weiss said. In both cases, Wang implanted Medtronic’s controversial bone-growth product in an “off-label” way not specifically approved by the Food and Drug Administration, according to the lawsuits.ĭoctors are legally allowed to use medications and devices in an unapproved manner, if they think it’s the best way to treat patients. But the plaintiffs argued that Wang deceived them by failing to obtain their consent for the “off-label” use and by not disclosing the tens of thousands of dollars in financial support he had received from Medtronic over the years.Īnd Lew alleged that Medtronic promoted off-label use of its products to Wang and UCLA, which generally is not allowed under federal law. The two patients alleged their surgeries led to complications, recurring pain and the need for additional operations. The regents agreed to pay $4.2 million to Jerome Lew, a 52-year-old screenwriter in Orange County, and $4.25 million to Ralph Weiss, a 61-year-old attorney in Calabasas. Jeffrey Wang, UCLA and Medtronic, the world’s largest medical-device company. The settlements were approved last week in separate Los Angeles County Superior Court cases that focused on the financial ties among the surgeon, Dr. The University of California regents have agreed to pay nearly $8.5 million to settle two lawsuits alleging a well-known UCLA spine surgeon failed to disclose his conflicts of interest with a leading device maker before using the company’s products in harmful surgeries.

Insight provides an in-depth look at health care issues in and affecting California.